Therefore, we chose 2-APB (200 μM, 24 h) in subsequent experiments and used a second inhibitor, Gin Rd, to confirm the effect of TRPM7 inhibition in breast cancer cells. This evidence concerns the gene TRPM7 and breast carcinoma.